Sunil Sharma

HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist

J. Qi, J. Bradner, K. Bhalla, 2015, Leukemia.

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.

Xiaoping Su, K. Bhalla, T. Kadia, 2023, Leukemia.